|Day Low/High||66.01 / 70.71|
|52 Wk Low/High||13.00 / 122.81|
Here's what was bad -- and good, and better -- about these numbers. "Apple's shares drop back under $500 a share, never breaching $600 to the upside and spending most of the year under $525 a share as profit estimates are again shaved. (Icahn dumps ...
If you don't place your bets now, you could fall behind for the rest of the year.
Japan's Suntory Holdings said it will buy liquor company Beam for $16 billion, including debt -- receiving iconic American brands like Jim Beam and Maker's Mark.
Company news drives the premarket as futures sag ahead of earnings.
I can't think of a worse portfolio to have right now than what Ackman's Gotham has been able to cobble together.
Want to live in Mad Men style? The stocks in the TheStreet's Mad Men portfolio will make that happen.
Gilles Bogaert, CFO of Pernod Ricard, offers his outlook for the rest of 2013 and discusses the company's emerging markets strategy.
U.S. regulators say they will not approve Novo Nordisk's new long-acting insulin Tresiba until more testing of it is conducted.
Kevin Dreyer, Associate Portfolio Manager of The Gabelli Asset Fund, discusses his top sin stock picks.
TheStreet hits the street or rather the bar in this case as Brian Sozzi and Debra Borchardt take a look at alcohol stocks.
CVS Caremark and Beam Inc. offer investors a greater probability of advance if market woes continue.
Whiskey industry expert David Clelland explains why the market is so hot and talks about his new private club, 1494.
Next week will be another busy week for corporate earnings reports, including those from big blue-chip stocks and web-based companies.
Stocks were poised for a moderately higher ahead of this highly anticipated monthly event.